MRA 6/1/2 Vol X (230)
MRA 6/1/2 Vol X (230) is the official BoMRA identifier for “Retention of Products on the Botswana Medicines Registers for the 2024/2025 Financial Year”. MRA 6/1/2 Vol X (230) is the official identifier BoMRA uses for this instrument.
- Instrument
- MRA
- Full name
- MRA 6/1/2 Vol X (230)
- Category
- Registration
- Authority source
- English
- Readable HTML
- 0 articles · 1 language version
- Published
- 2023-12-18
- Effective
- —
Open a language version
Each version has stable article anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
Retention of Products on the Botswana Medicines Registers for the 2024/2025 Financial Year
BoMRA's annual retention-fee circular for the 2024/2025 financial year, reference MRA 6/1/2 Vol X (230), dated 18 December 2023 and signed by the Acting Chief Executive Officer. It is the notice that keeps a registration alive: it states the section 24(4) annual-submission duty, requires marketing authorisation holders to price their retained products through the BRIMS self-service portal, sets 31 March 2024 as the payment deadline and April 2024 as the date products fall off the register, and lists the fees "as per Regulations of 2019" — BWP 1,000 for an imported or locally manufactured new chemical entity, BWP 1,000 for a locally manufactured NCE, BWP 500 for a locally manufactured generic, BWP 400 for complementary medicines and BWP 915 for veterinary medicines. Note what the fee lines do NOT contain: there is no medical-device line in this circular. It is a medicines-only notice, ingested because it is the register-maintenance instrument a device holder meets in practice, not because it sets a device fee.
MRA 6/1/2 Vol X (230) is the official identifier BoMRA uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.